Advances in genomics have vastly increased our understanding of inherited cancer risk and underlying cancer predisposition syndromes, thereby underpinning a revolution in the diagnosis and treatment of cancer itself. Concern regarding family history of cancer is a common presentation within primary care. This article provides an overview of the role of primary care practitioners in the clinical identification and management of inherited cancer risk within primary care including risk assessment, screening and surveillance. The article will consider management issues, including access to genomic testing and advice on risk-reduction measures. The role of genomics in cancer diagnosis and treatment and future applications will be outlined.
Dent T, Chowdhury S, Pashayan N, et al. (2014). Stratified screening for cancer; Recommendations and analysis from the COGS project. Available at: www.phgfoundation.org/documents/348_1391164316.pdf (accessed May 2020).
EvansDGBrentnallAByersH, et al.(2016) The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: A case–control study. Journal of Medical Genetics54: 111–113. DOI: 10.1136/jmedgenet-2016-104125.
7.
EvansDGHarknessEFPlaskocinskaI, et al.(2017) Pathology update to the Manchester Scoring System based on testing in over 4000 families. Journal of Medical Genetics54: 674–668. DOI: 10.1136/jmedgenet-2017-104584.
HanahanDWeinbergRA (2011) Hallmarks of cancer: The next generation. Cell144(5): 646–674.
10.
KuchenbaeckerKHopperJBarnesD, et al.(2017) Risks of breast, ovarian and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. Journal of the American Medical Association317(23): 2402–2416. DOI: 10.1001/jama.2017.7112.
MaddockCSchrijversDTurcoMRD, et al.(2011) To know or not to know? Not the only question in familial breast cancer risk communication. Ecancermedicalscience5: 239DOI: 10.3332/ecancer.2011.239.
13.
MandelkarDDonoghueMTalukdarS, et al.(2019) Germline-focussed analysis of tumour-only sequencing: Recommendations from the ESMO Precision Medicine Working Group. Annals of Oncology30(8): 1221–1231. DOI: 10.1093/annonc/mdz136.
14.
Martin AR, Williams E, Foulger RE, et al. (2019) PanelAPp crowdsources expert knowledge to establish consensus diagnostic gene panels. Nature Genetics 51(11): 1560–1565. DOI: 10.1038/s41588-019-0528-2.
15.
Monahan K, Bradshaw N, et al. (2019) Guidelines for the management of hereditary colorectal cancer from the British Society of Gastroenterology (BSG)/Association of Coloproctology of Great Britain and Ireland (ACPGBI)/ United Kingdom Cancer Genetics Group (UKCGG). Gut 2020 (69): 411–444.
NICE (2019a) Familial breast cancer: Classification, care and managing breast cancer and related risks in people with a family history of breast cancer. Available at: www.nice.org.uk/Guidance/CG164 (accessed March 2020).
UBQO (2020) Cancer genetics: Hereditary cancer risk assessment and referral guide for clinicians. Available at: www.ubqo.com/cancergenetics (accessed June 2020).
